{
  "ticker": "JNJ",
  "entities": [
    {
      "text": "Johnson & Johnson",
      "label": "ORG",
      "start": 0,
      "end": 17,
      "sentence": "Johnson & Johnson (JNJ) shares moved today on a mix of analyst actions, pipeline progress and broader market sentiment.",
      "context": "Johnson & Johnson (JNJ) shares moved today on a mix of analyst acti",
      "is_company": true,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "JNJ",
      "label": "ORG",
      "start": 19,
      "end": 22,
      "sentence": "Johnson & Johnson (JNJ) shares moved today on a mix of analyst actions, pipeline progress and broader market sentiment.",
      "context": "Johnson & Johnson (JNJ) shares moved today on a mix of analyst actions,",
      "is_company": true,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "today",
      "label": "DATE",
      "start": 37,
      "end": 42,
      "sentence": "Johnson & Johnson (JNJ) shares moved today on a mix of analyst actions, pipeline progress and broader market sentiment.",
      "context": "Johnson & Johnson (JNJ) shares moved today on a mix of analyst actions, pipeline progress an",
      "is_company": false,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "Morgan Stanley",
      "label": "ORG",
      "start": 203,
      "end": 217,
      "sentence": "Positive Sentiment:\nMorgan Stanley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rating, reflecting confidence in the company’s outlook.",
      "context": "cing the stock’s performance:\nPositive Sentiment:\nMorgan Stanley raised its price target on JNJ from $169 to $171",
      "is_company": true,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "JNJ",
      "label": "ORG",
      "start": 245,
      "end": 248,
      "sentence": "Positive Sentiment:\nMorgan Stanley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rating, reflecting confidence in the company’s outlook.",
      "context": "timent:\nMorgan Stanley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rati",
      "is_company": true,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "169",
      "label": "MONEY",
      "start": 255,
      "end": 258,
      "sentence": "Positive Sentiment:\nMorgan Stanley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rating, reflecting confidence in the company’s outlook.",
      "context": "rgan Stanley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rating, reflec",
      "is_company": false,
      "is_person": false,
      "is_location": false,
      "is_financial": true
    },
    {
      "text": "171",
      "label": "MONEY",
      "start": 263,
      "end": 266,
      "sentence": "Positive Sentiment:\nMorgan Stanley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rating, reflecting confidence in the company’s outlook.",
      "context": "nley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rating, reflecting con",
      "is_company": false,
      "is_person": false,
      "is_location": false,
      "is_financial": true
    },
    {
      "text": "Morgan Stanley Forecast",
      "label": "ORG",
      "start": 350,
      "end": 374,
      "sentence": "Morgan Stanley Forecast\nPositive Sentiment:",
      "context": ", reflecting confidence in the company’s outlook.\nMorgan Stanley Forecast\nPositive Sentiment:\nJNJ submitted a supplemental N",
      "is_company": true,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "JNJ",
      "label": "ORG",
      "start": 394,
      "end": 397,
      "sentence": "JNJ submitted a supplemental NDA to the FDA for its schizophrenia drug Caplyta based on strong relapse-prevention data, bolstering its psychiatric portfolio.",
      "context": "look.\nMorgan Stanley Forecast\nPositive Sentiment:\nJNJ submitted a supplemental NDA to the FDA for its s",
      "is_company": true,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "FDA",
      "label": "ORG",
      "start": 434,
      "end": 437,
      "sentence": "JNJ submitted a supplemental NDA to the FDA for its schizophrenia drug Caplyta based on strong relapse-prevention data, bolstering its psychiatric portfolio.",
      "context": "entiment:\nJNJ submitted a supplemental NDA to the FDA for its schizophrenia drug Caplyta based on stron",
      "is_company": true,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "Caplyta",
      "label": "PRODUCT",
      "start": 465,
      "end": 472,
      "sentence": "JNJ submitted a supplemental NDA to the FDA for its schizophrenia drug Caplyta based on strong relapse-prevention data, bolstering its psychiatric portfolio.",
      "context": "emental NDA to the FDA for its schizophrenia drug Caplyta based on strong relapse-prevention data, bolsteri",
      "is_company": false,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "MedTech",
      "label": "ORG",
      "start": 712,
      "end": 719,
      "sentence": "The company appointed a new Chief Medical Officer for its Electrophysiology business, enhancing leadership in a key MedTech segment.",
      "context": "hysiology business, enhancing leadership in a key MedTech segment.\nNew CMO Appointment\nPositive Sentiment:",
      "is_company": true,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "JNJ",
      "label": "ORG",
      "start": 769,
      "end": 772,
      "sentence": "New CMO Appointment\nPositive Sentiment:\nJNJ is featured among three AI-driven medical device stocks to watch in 2025, highlighting its advances in diagnostics and surgical tech.",
      "context": "segment.\nNew CMO Appointment\nPositive Sentiment:\nJNJ is featured among three AI-driven medical device",
      "is_company": true,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "three",
      "label": "CARDINAL",
      "start": 791,
      "end": 796,
      "sentence": "New CMO Appointment\nPositive Sentiment:\nJNJ is featured among three AI-driven medical device stocks to watch in 2025, highlighting its advances in diagnostics and surgical tech.",
      "context": "intment\nPositive Sentiment:\nJNJ is featured among three AI-driven medical device stocks to watch in 2025,",
      "is_company": false,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "2025",
      "label": "DATE",
      "start": 841,
      "end": 845,
      "sentence": "New CMO Appointment\nPositive Sentiment:\nJNJ is featured among three AI-driven medical device stocks to watch in 2025, highlighting its advances in diagnostics and surgical tech.",
      "context": "three AI-driven medical device stocks to watch in 2025, highlighting its advances in diagnostics and sur",
      "is_company": false,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "Q2",
      "label": "DATE",
      "start": 988,
      "end": 990,
      "sentence": "AI-Driven Devices Article\nNeutral Sentiment:\nWall Street analysts released their Q2 estimates for JNJ’s top- and bottom-line metrics ahead of its July 16 earnings report.",
      "context": "al Sentiment:\nWall Street analysts released their Q2 estimates for JNJ’s top- and bottom-line metrics",
      "is_company": false,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "JNJ",
      "label": "ORG",
      "start": 1005,
      "end": 1008,
      "sentence": "AI-Driven Devices Article\nNeutral Sentiment:\nWall Street analysts released their Q2 estimates for JNJ’s top- and bottom-line metrics ahead of its July 16 earnings report.",
      "context": "l Street analysts released their Q2 estimates for JNJ’s top- and bottom-line metrics ahead of its July",
      "is_company": true,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "July 16",
      "label": "DATE",
      "start": 1053,
      "end": 1060,
      "sentence": "AI-Driven Devices Article\nNeutral Sentiment:\nWall Street analysts released their Q2 estimates for JNJ’s top- and bottom-line metrics ahead of its July 16 earnings report.",
      "context": "r JNJ’s top- and bottom-line metrics ahead of its July 16 earnings report.\nQ2 Outlook\nNeutral Sentiment:\nBe",
      "is_company": false,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "Q2",
      "label": "DATE",
      "start": 1078,
      "end": 1080,
      "sentence": "Q2 Outlook\nNeutral Sentiment:",
      "context": "ine metrics ahead of its July 16 earnings report.\nQ2 Outlook\nNeutral Sentiment:\nBenzinga detailed rece",
      "is_company": false,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "Benzinga",
      "label": "ORG",
      "start": 1108,
      "end": 1116,
      "sentence": "Benzinga detailed recent forecast adjustments from the most accurate analysts as JNJ gears up for its Q2 print.",
      "context": "16 earnings report.\nQ2 Outlook\nNeutral Sentiment:\nBenzinga detailed recent forecast adjustments from the mos",
      "is_company": true,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "JNJ",
      "label": "ORG",
      "start": 1189,
      "end": 1192,
      "sentence": "Benzinga detailed recent forecast adjustments from the most accurate analysts as JNJ gears up for its Q2 print.",
      "context": "st adjustments from the most accurate analysts as JNJ gears up for its Q2 print.\nForecast Changes\nNeutr",
      "is_company": true,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "Q2",
      "label": "DATE",
      "start": 1210,
      "end": 1212,
      "sentence": "Benzinga detailed recent forecast adjustments from the most accurate analysts as JNJ gears up for its Q2 print.",
      "context": "he most accurate analysts as JNJ gears up for its Q2 print.\nForecast Changes\nNeutral Sentiment:\nEight",
      "is_company": false,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "Eight",
      "label": "CARDINAL",
      "start": 1256,
      "end": 1261,
      "sentence": "Eight analyst projections on JNJ’s long-term growth—covering sales, R&D spend and margins—were published by Benzinga.",
      "context": "its Q2 print.\nForecast Changes\nNeutral Sentiment:\nEight analyst projections on JNJ’s long-term growth—cov",
      "is_company": false,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "JNJ",
      "label": "ORG",
      "start": 1285,
      "end": 1288,
      "sentence": "Eight analyst projections on JNJ’s long-term growth—covering sales, R&D spend and margins—were published by Benzinga.",
      "context": "s\nNeutral Sentiment:\nEight analyst projections on JNJ’s long-term growth—covering sales, R&D spend and",
      "is_company": true,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "Benzinga",
      "label": "ORG",
      "start": 1364,
      "end": 1372,
      "sentence": "Eight analyst projections on JNJ’s long-term growth—covering sales, R&D spend and margins—were published by Benzinga.",
      "context": "ng sales, R&D spend and margins—were published by Benzinga.\nAnalyst Projections\nNeutral Sentiment:\nJNJ was r",
      "is_company": true,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "JNJ",
      "label": "ORG",
      "start": 1413,
      "end": 1416,
      "sentence": "JNJ was repeatedly cited in dividend-stock roundups, underscoring its appeal for income-seeking investors:",
      "context": "Benzinga.\nAnalyst Projections\nNeutral Sentiment:\nJNJ was repeatedly cited in dividend-stock roundups,",
      "is_company": true,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "5",
      "label": "MONEY",
      "start": 1585,
      "end": 1586,
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "context": "Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-mark",
      "is_company": false,
      "is_person": false,
      "is_location": false,
      "is_financial": true
    },
    {
      "text": "K",
      "label": "MONEY",
      "start": 1586,
      "end": 1587,
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "context": "ividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-marke",
      "is_company": false,
      "is_person": false,
      "is_location": false,
      "is_financial": true
    },
    {
      "text": "300",
      "label": "MONEY",
      "start": 1594,
      "end": 1597,
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "context": "Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines",
      "is_company": false,
      "is_person": false,
      "is_location": false,
      "is_financial": true
    },
    {
      "text": "K",
      "label": "MONEY",
      "start": 1597,
      "end": 1598,
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "context": "ks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines",
      "is_company": false,
      "is_person": false,
      "is_location": false,
      "is_financial": true
    },
    {
      "text": "JNJ",
      "label": "ORG",
      "start": 1604,
      "end": 1607,
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "context": "dend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driv",
      "is_company": true,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "Trump",
      "label": "PERSON",
      "start": 1673,
      "end": 1678,
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "context": "ent:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwin",
      "is_company": false,
      "is_person": true,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "Canada",
      "label": "GPE",
      "start": 1704,
      "end": 1710,
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "context": "riven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial",
      "is_company": false,
      "is_person": false,
      "is_location": true,
      "is_financial": false
    },
    {
      "text": "JNJ",
      "label": "ORG",
      "start": 1873,
      "end": 1876,
      "sentence": "Tariff Threats\nOverall, positive pipeline developments and analyst upgrades provided upward momentum for JNJ shares, while macro trade-related concerns applied some downward pressure.",
      "context": "and analyst upgrades provided upward momentum for JNJ shares, while macro trade-related concerns applie",
      "is_company": true,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "1+ days ago",
      "label": "DATE",
      "start": 1959,
      "end": 1970,
      "sentence": "Posted 1+ days ago\nAI Generated.",
      "context": "d concerns applied some downward pressure.\nPosted 1+ days ago\nAI Generated. May Contain Errors.",
      "is_company": false,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    },
    {
      "text": "AI Generated",
      "label": "ORG",
      "start": 1971,
      "end": 1983,
      "sentence": "Posted 1+ days ago\nAI Generated.",
      "context": "pplied some downward pressure.\nPosted 1+ days ago\nAI Generated. May Contain Errors.",
      "is_company": true,
      "is_person": false,
      "is_location": false,
      "is_financial": false
    }
  ],
  "relationships": [
    {
      "type": "SVO",
      "subject": "Stanley",
      "verb": "raised",
      "object": "target",
      "sentence": "Positive Sentiment:\nMorgan Stanley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rating, reflecting confidence in the company’s outlook.",
      "importance": 8
    },
    {
      "type": "SVO",
      "subject": "JNJ",
      "verb": "submitted",
      "object": "NDA",
      "sentence": "JNJ submitted a supplemental NDA to the FDA for its schizophrenia drug Caplyta based on strong relapse-prevention data, bolstering its psychiatric portfolio.",
      "importance": 5
    },
    {
      "type": "SVO",
      "subject": "company",
      "verb": "appointed",
      "object": "Officer",
      "sentence": "The company appointed a new Chief Medical Officer for its Electrophysiology business, enhancing leadership in a key MedTech segment.",
      "importance": 1
    },
    {
      "type": "SVO",
      "subject": "analysts",
      "verb": "released",
      "object": "estimates",
      "sentence": "AI-Driven Devices Article\nNeutral Sentiment:\nWall Street analysts released their Q2 estimates for JNJ’s top- and bottom-line metrics ahead of its July 16 earnings report.",
      "importance": 6
    },
    {
      "type": "SVO",
      "subject": "Benzinga",
      "verb": "detailed",
      "object": "adjustments",
      "sentence": "Benzinga detailed recent forecast adjustments from the most accurate analysts as JNJ gears up for its Q2 print.",
      "importance": 4
    },
    {
      "type": "SVO",
      "subject": "developments",
      "verb": "provided",
      "object": "momentum",
      "sentence": "Tariff Threats\nOverall, positive pipeline developments and analyst upgrades provided upward momentum for JNJ shares, while macro trade-related concerns applied some downward pressure.",
      "importance": 5
    },
    {
      "type": "SVO",
      "subject": "concerns",
      "verb": "applied",
      "object": "pressure",
      "sentence": "Tariff Threats\nOverall, positive pipeline developments and analyst upgrades provided upward momentum for JNJ shares, while macro trade-related concerns applied some downward pressure.",
      "importance": 5
    },
    {
      "type": "co-occurrence",
      "entity1": "Johnson",
      "entity1_type": "ORG",
      "entity2": "&",
      "entity2_type": "ORG",
      "sentence": "Johnson & Johnson (JNJ) shares moved today on a mix of analyst actions, pipeline progress and broader market sentiment.",
      "distance": 1
    },
    {
      "type": "co-occurrence",
      "entity1": "Johnson",
      "entity1_type": "ORG",
      "entity2": "Johnson",
      "entity2_type": "ORG",
      "sentence": "Johnson & Johnson (JNJ) shares moved today on a mix of analyst actions, pipeline progress and broader market sentiment.",
      "distance": 2
    },
    {
      "type": "co-occurrence",
      "entity1": "Johnson",
      "entity1_type": "ORG",
      "entity2": "JNJ",
      "entity2_type": "ORG",
      "sentence": "Johnson & Johnson (JNJ) shares moved today on a mix of analyst actions, pipeline progress and broader market sentiment.",
      "distance": 4
    },
    {
      "type": "co-occurrence",
      "entity1": "Johnson",
      "entity1_type": "ORG",
      "entity2": "today",
      "entity2_type": "DATE",
      "sentence": "Johnson & Johnson (JNJ) shares moved today on a mix of analyst actions, pipeline progress and broader market sentiment.",
      "distance": 8
    },
    {
      "type": "co-occurrence",
      "entity1": "&",
      "entity1_type": "ORG",
      "entity2": "Johnson",
      "entity2_type": "ORG",
      "sentence": "Johnson & Johnson (JNJ) shares moved today on a mix of analyst actions, pipeline progress and broader market sentiment.",
      "distance": 1
    },
    {
      "type": "co-occurrence",
      "entity1": "&",
      "entity1_type": "ORG",
      "entity2": "JNJ",
      "entity2_type": "ORG",
      "sentence": "Johnson & Johnson (JNJ) shares moved today on a mix of analyst actions, pipeline progress and broader market sentiment.",
      "distance": 3
    },
    {
      "type": "co-occurrence",
      "entity1": "&",
      "entity1_type": "ORG",
      "entity2": "today",
      "entity2_type": "DATE",
      "sentence": "Johnson & Johnson (JNJ) shares moved today on a mix of analyst actions, pipeline progress and broader market sentiment.",
      "distance": 7
    },
    {
      "type": "co-occurrence",
      "entity1": "Johnson",
      "entity1_type": "ORG",
      "entity2": "JNJ",
      "entity2_type": "ORG",
      "sentence": "Johnson & Johnson (JNJ) shares moved today on a mix of analyst actions, pipeline progress and broader market sentiment.",
      "distance": 2
    },
    {
      "type": "co-occurrence",
      "entity1": "Johnson",
      "entity1_type": "ORG",
      "entity2": "today",
      "entity2_type": "DATE",
      "sentence": "Johnson & Johnson (JNJ) shares moved today on a mix of analyst actions, pipeline progress and broader market sentiment.",
      "distance": 6
    },
    {
      "type": "co-occurrence",
      "entity1": "JNJ",
      "entity1_type": "ORG",
      "entity2": "today",
      "entity2_type": "DATE",
      "sentence": "Johnson & Johnson (JNJ) shares moved today on a mix of analyst actions, pipeline progress and broader market sentiment.",
      "distance": 4
    },
    {
      "type": "co-occurrence",
      "entity1": "Morgan",
      "entity1_type": "ORG",
      "entity2": "Stanley",
      "entity2_type": "ORG",
      "sentence": "Positive Sentiment:\nMorgan Stanley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rating, reflecting confidence in the company’s outlook.",
      "distance": 1
    },
    {
      "type": "co-occurrence",
      "entity1": "Morgan",
      "entity1_type": "ORG",
      "entity2": "JNJ",
      "entity2_type": "ORG",
      "sentence": "Positive Sentiment:\nMorgan Stanley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rating, reflecting confidence in the company’s outlook.",
      "distance": 7
    },
    {
      "type": "co-occurrence",
      "entity1": "Morgan",
      "entity1_type": "ORG",
      "entity2": "169",
      "entity2_type": "MONEY",
      "sentence": "Positive Sentiment:\nMorgan Stanley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rating, reflecting confidence in the company’s outlook.",
      "distance": 10
    },
    {
      "type": "co-occurrence",
      "entity1": "Morgan",
      "entity1_type": "ORG",
      "entity2": "171",
      "entity2_type": "MONEY",
      "sentence": "Positive Sentiment:\nMorgan Stanley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rating, reflecting confidence in the company’s outlook.",
      "distance": 13
    },
    {
      "type": "co-occurrence",
      "entity1": "Stanley",
      "entity1_type": "ORG",
      "entity2": "JNJ",
      "entity2_type": "ORG",
      "sentence": "Positive Sentiment:\nMorgan Stanley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rating, reflecting confidence in the company’s outlook.",
      "distance": 6
    },
    {
      "type": "co-occurrence",
      "entity1": "Stanley",
      "entity1_type": "ORG",
      "entity2": "169",
      "entity2_type": "MONEY",
      "sentence": "Positive Sentiment:\nMorgan Stanley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rating, reflecting confidence in the company’s outlook.",
      "distance": 9
    },
    {
      "type": "co-occurrence",
      "entity1": "Stanley",
      "entity1_type": "ORG",
      "entity2": "171",
      "entity2_type": "MONEY",
      "sentence": "Positive Sentiment:\nMorgan Stanley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rating, reflecting confidence in the company’s outlook.",
      "distance": 12
    },
    {
      "type": "co-occurrence",
      "entity1": "JNJ",
      "entity1_type": "ORG",
      "entity2": "169",
      "entity2_type": "MONEY",
      "sentence": "Positive Sentiment:\nMorgan Stanley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rating, reflecting confidence in the company’s outlook.",
      "distance": 3
    },
    {
      "type": "co-occurrence",
      "entity1": "JNJ",
      "entity1_type": "ORG",
      "entity2": "171",
      "entity2_type": "MONEY",
      "sentence": "Positive Sentiment:\nMorgan Stanley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rating, reflecting confidence in the company’s outlook.",
      "distance": 6
    },
    {
      "type": "co-occurrence",
      "entity1": "169",
      "entity1_type": "MONEY",
      "entity2": "171",
      "entity2_type": "MONEY",
      "sentence": "Positive Sentiment:\nMorgan Stanley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rating, reflecting confidence in the company’s outlook.",
      "distance": 3
    },
    {
      "type": "co-occurrence",
      "entity1": "Morgan",
      "entity1_type": "ORG",
      "entity2": "Stanley",
      "entity2_type": "ORG",
      "sentence": "Morgan Stanley Forecast\nPositive Sentiment:",
      "distance": 1
    },
    {
      "type": "co-occurrence",
      "entity1": "Morgan",
      "entity1_type": "ORG",
      "entity2": "Forecast",
      "entity2_type": "ORG",
      "sentence": "Morgan Stanley Forecast\nPositive Sentiment:",
      "distance": 2
    },
    {
      "type": "co-occurrence",
      "entity1": "Morgan",
      "entity1_type": "ORG",
      "entity2": "\n",
      "entity2_type": "ORG",
      "sentence": "Morgan Stanley Forecast\nPositive Sentiment:",
      "distance": 3
    },
    {
      "type": "co-occurrence",
      "entity1": "Stanley",
      "entity1_type": "ORG",
      "entity2": "Forecast",
      "entity2_type": "ORG",
      "sentence": "Morgan Stanley Forecast\nPositive Sentiment:",
      "distance": 1
    },
    {
      "type": "co-occurrence",
      "entity1": "Stanley",
      "entity1_type": "ORG",
      "entity2": "\n",
      "entity2_type": "ORG",
      "sentence": "Morgan Stanley Forecast\nPositive Sentiment:",
      "distance": 2
    },
    {
      "type": "co-occurrence",
      "entity1": "Forecast",
      "entity1_type": "ORG",
      "entity2": "\n",
      "entity2_type": "ORG",
      "sentence": "Morgan Stanley Forecast\nPositive Sentiment:",
      "distance": 1
    },
    {
      "type": "co-occurrence",
      "entity1": "JNJ",
      "entity1_type": "ORG",
      "entity2": "FDA",
      "entity2_type": "ORG",
      "sentence": "JNJ submitted a supplemental NDA to the FDA for its schizophrenia drug Caplyta based on strong relapse-prevention data, bolstering its psychiatric portfolio.",
      "distance": 7
    },
    {
      "type": "co-occurrence",
      "entity1": "JNJ",
      "entity1_type": "ORG",
      "entity2": "Caplyta",
      "entity2_type": "PRODUCT",
      "sentence": "JNJ submitted a supplemental NDA to the FDA for its schizophrenia drug Caplyta based on strong relapse-prevention data, bolstering its psychiatric portfolio.",
      "distance": 12
    },
    {
      "type": "co-occurrence",
      "entity1": "FDA",
      "entity1_type": "ORG",
      "entity2": "Caplyta",
      "entity2_type": "PRODUCT",
      "sentence": "JNJ submitted a supplemental NDA to the FDA for its schizophrenia drug Caplyta based on strong relapse-prevention data, bolstering its psychiatric portfolio.",
      "distance": 5
    },
    {
      "type": "co-occurrence",
      "entity1": "JNJ",
      "entity1_type": "ORG",
      "entity2": "three",
      "entity2_type": "CARDINAL",
      "sentence": "New CMO Appointment\nPositive Sentiment:\nJNJ is featured among three AI-driven medical device stocks to watch in 2025, highlighting its advances in diagnostics and surgical tech.",
      "distance": 4
    },
    {
      "type": "co-occurrence",
      "entity1": "JNJ",
      "entity1_type": "ORG",
      "entity2": "2025",
      "entity2_type": "DATE",
      "sentence": "New CMO Appointment\nPositive Sentiment:\nJNJ is featured among three AI-driven medical device stocks to watch in 2025, highlighting its advances in diagnostics and surgical tech.",
      "distance": 14
    },
    {
      "type": "co-occurrence",
      "entity1": "three",
      "entity1_type": "CARDINAL",
      "entity2": "2025",
      "entity2_type": "DATE",
      "sentence": "New CMO Appointment\nPositive Sentiment:\nJNJ is featured among three AI-driven medical device stocks to watch in 2025, highlighting its advances in diagnostics and surgical tech.",
      "distance": 10
    },
    {
      "type": "co-occurrence",
      "entity1": "Q2",
      "entity1_type": "DATE",
      "entity2": "JNJ",
      "entity2_type": "ORG",
      "sentence": "AI-Driven Devices Article\nNeutral Sentiment:\nWall Street analysts released their Q2 estimates for JNJ’s top- and bottom-line metrics ahead of its July 16 earnings report.",
      "distance": 3
    },
    {
      "type": "co-occurrence",
      "entity1": "Q2",
      "entity1_type": "DATE",
      "entity2": "July",
      "entity2_type": "DATE",
      "sentence": "AI-Driven Devices Article\nNeutral Sentiment:\nWall Street analysts released their Q2 estimates for JNJ’s top- and bottom-line metrics ahead of its July 16 earnings report.",
      "distance": 14
    },
    {
      "type": "co-occurrence",
      "entity1": "Q2",
      "entity1_type": "DATE",
      "entity2": "16",
      "entity2_type": "DATE",
      "sentence": "AI-Driven Devices Article\nNeutral Sentiment:\nWall Street analysts released their Q2 estimates for JNJ’s top- and bottom-line metrics ahead of its July 16 earnings report.",
      "distance": 15
    },
    {
      "type": "co-occurrence",
      "entity1": "JNJ",
      "entity1_type": "ORG",
      "entity2": "July",
      "entity2_type": "DATE",
      "sentence": "AI-Driven Devices Article\nNeutral Sentiment:\nWall Street analysts released their Q2 estimates for JNJ’s top- and bottom-line metrics ahead of its July 16 earnings report.",
      "distance": 11
    },
    {
      "type": "co-occurrence",
      "entity1": "JNJ",
      "entity1_type": "ORG",
      "entity2": "16",
      "entity2_type": "DATE",
      "sentence": "AI-Driven Devices Article\nNeutral Sentiment:\nWall Street analysts released their Q2 estimates for JNJ’s top- and bottom-line metrics ahead of its July 16 earnings report.",
      "distance": 12
    },
    {
      "type": "co-occurrence",
      "entity1": "July",
      "entity1_type": "DATE",
      "entity2": "16",
      "entity2_type": "DATE",
      "sentence": "AI-Driven Devices Article\nNeutral Sentiment:\nWall Street analysts released their Q2 estimates for JNJ’s top- and bottom-line metrics ahead of its July 16 earnings report.",
      "distance": 1
    },
    {
      "type": "co-occurrence",
      "entity1": "Benzinga",
      "entity1_type": "ORG",
      "entity2": "JNJ",
      "entity2_type": "ORG",
      "sentence": "Benzinga detailed recent forecast adjustments from the most accurate analysts as JNJ gears up for its Q2 print.",
      "distance": 11
    },
    {
      "type": "co-occurrence",
      "entity1": "Benzinga",
      "entity1_type": "ORG",
      "entity2": "Q2",
      "entity2_type": "DATE",
      "sentence": "Benzinga detailed recent forecast adjustments from the most accurate analysts as JNJ gears up for its Q2 print.",
      "distance": 16
    },
    {
      "type": "co-occurrence",
      "entity1": "JNJ",
      "entity1_type": "ORG",
      "entity2": "Q2",
      "entity2_type": "DATE",
      "sentence": "Benzinga detailed recent forecast adjustments from the most accurate analysts as JNJ gears up for its Q2 print.",
      "distance": 5
    },
    {
      "type": "co-occurrence",
      "entity1": "Eight",
      "entity1_type": "CARDINAL",
      "entity2": "JNJ",
      "entity2_type": "ORG",
      "sentence": "Eight analyst projections on JNJ’s long-term growth—covering sales, R&D spend and margins—were published by Benzinga.",
      "distance": 4
    },
    {
      "type": "co-occurrence",
      "entity1": "Eight",
      "entity1_type": "CARDINAL",
      "entity2": "Benzinga",
      "entity2_type": "ORG",
      "sentence": "Eight analyst projections on JNJ’s long-term growth—covering sales, R&D spend and margins—were published by Benzinga.",
      "distance": 22
    },
    {
      "type": "co-occurrence",
      "entity1": "JNJ",
      "entity1_type": "ORG",
      "entity2": "Benzinga",
      "entity2_type": "ORG",
      "sentence": "Eight analyst projections on JNJ’s long-term growth—covering sales, R&D spend and margins—were published by Benzinga.",
      "distance": 18
    },
    {
      "type": "co-occurrence",
      "entity1": "5",
      "entity1_type": "MONEY",
      "entity2": "K",
      "entity2_type": "MONEY",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 1
    },
    {
      "type": "co-occurrence",
      "entity1": "5",
      "entity1_type": "MONEY",
      "entity2": "300",
      "entity2_type": "MONEY",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 4
    },
    {
      "type": "co-occurrence",
      "entity1": "5",
      "entity1_type": "MONEY",
      "entity2": "K",
      "entity2_type": "MONEY",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 5
    },
    {
      "type": "co-occurrence",
      "entity1": "5",
      "entity1_type": "MONEY",
      "entity2": "JNJ",
      "entity2_type": "ORG",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 7
    },
    {
      "type": "co-occurrence",
      "entity1": "5",
      "entity1_type": "MONEY",
      "entity2": "Trump",
      "entity2_type": "PERSON",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 21
    },
    {
      "type": "co-occurrence",
      "entity1": "5",
      "entity1_type": "MONEY",
      "entity2": "Canada",
      "entity2_type": "GPE",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 26
    },
    {
      "type": "co-occurrence",
      "entity1": "K",
      "entity1_type": "MONEY",
      "entity2": "300",
      "entity2_type": "MONEY",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 3
    },
    {
      "type": "co-occurrence",
      "entity1": "K",
      "entity1_type": "MONEY",
      "entity2": "K",
      "entity2_type": "MONEY",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 4
    },
    {
      "type": "co-occurrence",
      "entity1": "K",
      "entity1_type": "MONEY",
      "entity2": "JNJ",
      "entity2_type": "ORG",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 6
    },
    {
      "type": "co-occurrence",
      "entity1": "K",
      "entity1_type": "MONEY",
      "entity2": "Trump",
      "entity2_type": "PERSON",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 20
    },
    {
      "type": "co-occurrence",
      "entity1": "K",
      "entity1_type": "MONEY",
      "entity2": "Canada",
      "entity2_type": "GPE",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 25
    },
    {
      "type": "co-occurrence",
      "entity1": "300",
      "entity1_type": "MONEY",
      "entity2": "K",
      "entity2_type": "MONEY",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 1
    },
    {
      "type": "co-occurrence",
      "entity1": "300",
      "entity1_type": "MONEY",
      "entity2": "JNJ",
      "entity2_type": "ORG",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 3
    },
    {
      "type": "co-occurrence",
      "entity1": "300",
      "entity1_type": "MONEY",
      "entity2": "Trump",
      "entity2_type": "PERSON",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 17
    },
    {
      "type": "co-occurrence",
      "entity1": "300",
      "entity1_type": "MONEY",
      "entity2": "Canada",
      "entity2_type": "GPE",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 22
    },
    {
      "type": "co-occurrence",
      "entity1": "K",
      "entity1_type": "MONEY",
      "entity2": "JNJ",
      "entity2_type": "ORG",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 2
    },
    {
      "type": "co-occurrence",
      "entity1": "K",
      "entity1_type": "MONEY",
      "entity2": "Trump",
      "entity2_type": "PERSON",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 16
    },
    {
      "type": "co-occurrence",
      "entity1": "K",
      "entity1_type": "MONEY",
      "entity2": "Canada",
      "entity2_type": "GPE",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 21
    },
    {
      "type": "co-occurrence",
      "entity1": "JNJ",
      "entity1_type": "ORG",
      "entity2": "Trump",
      "entity2_type": "PERSON",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 14
    },
    {
      "type": "co-occurrence",
      "entity1": "JNJ",
      "entity1_type": "ORG",
      "entity2": "Canada",
      "entity2_type": "GPE",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 19
    },
    {
      "type": "co-occurrence",
      "entity1": "Trump",
      "entity1_type": "PERSON",
      "entity2": "Canada",
      "entity2_type": "GPE",
      "sentence": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "distance": 5
    },
    {
      "type": "co-occurrence",
      "entity1": "1",
      "entity1_type": "DATE",
      "entity2": "+",
      "entity2_type": "DATE",
      "sentence": "Posted 1+ days ago\nAI Generated.",
      "distance": 1
    },
    {
      "type": "co-occurrence",
      "entity1": "1",
      "entity1_type": "DATE",
      "entity2": "days",
      "entity2_type": "DATE",
      "sentence": "Posted 1+ days ago\nAI Generated.",
      "distance": 2
    },
    {
      "type": "co-occurrence",
      "entity1": "1",
      "entity1_type": "DATE",
      "entity2": "ago",
      "entity2_type": "DATE",
      "sentence": "Posted 1+ days ago\nAI Generated.",
      "distance": 3
    },
    {
      "type": "co-occurrence",
      "entity1": "1",
      "entity1_type": "DATE",
      "entity2": "AI",
      "entity2_type": "ORG",
      "sentence": "Posted 1+ days ago\nAI Generated.",
      "distance": 5
    },
    {
      "type": "co-occurrence",
      "entity1": "1",
      "entity1_type": "DATE",
      "entity2": "Generated",
      "entity2_type": "ORG",
      "sentence": "Posted 1+ days ago\nAI Generated.",
      "distance": 6
    },
    {
      "type": "co-occurrence",
      "entity1": "+",
      "entity1_type": "DATE",
      "entity2": "days",
      "entity2_type": "DATE",
      "sentence": "Posted 1+ days ago\nAI Generated.",
      "distance": 1
    },
    {
      "type": "co-occurrence",
      "entity1": "+",
      "entity1_type": "DATE",
      "entity2": "ago",
      "entity2_type": "DATE",
      "sentence": "Posted 1+ days ago\nAI Generated.",
      "distance": 2
    },
    {
      "type": "co-occurrence",
      "entity1": "+",
      "entity1_type": "DATE",
      "entity2": "AI",
      "entity2_type": "ORG",
      "sentence": "Posted 1+ days ago\nAI Generated.",
      "distance": 4
    },
    {
      "type": "co-occurrence",
      "entity1": "+",
      "entity1_type": "DATE",
      "entity2": "Generated",
      "entity2_type": "ORG",
      "sentence": "Posted 1+ days ago\nAI Generated.",
      "distance": 5
    },
    {
      "type": "co-occurrence",
      "entity1": "days",
      "entity1_type": "DATE",
      "entity2": "ago",
      "entity2_type": "DATE",
      "sentence": "Posted 1+ days ago\nAI Generated.",
      "distance": 1
    },
    {
      "type": "co-occurrence",
      "entity1": "days",
      "entity1_type": "DATE",
      "entity2": "AI",
      "entity2_type": "ORG",
      "sentence": "Posted 1+ days ago\nAI Generated.",
      "distance": 3
    },
    {
      "type": "co-occurrence",
      "entity1": "days",
      "entity1_type": "DATE",
      "entity2": "Generated",
      "entity2_type": "ORG",
      "sentence": "Posted 1+ days ago\nAI Generated.",
      "distance": 4
    },
    {
      "type": "co-occurrence",
      "entity1": "ago",
      "entity1_type": "DATE",
      "entity2": "AI",
      "entity2_type": "ORG",
      "sentence": "Posted 1+ days ago\nAI Generated.",
      "distance": 2
    },
    {
      "type": "co-occurrence",
      "entity1": "ago",
      "entity1_type": "DATE",
      "entity2": "Generated",
      "entity2_type": "ORG",
      "sentence": "Posted 1+ days ago\nAI Generated.",
      "distance": 3
    },
    {
      "type": "co-occurrence",
      "entity1": "AI",
      "entity1_type": "ORG",
      "entity2": "Generated",
      "entity2_type": "ORG",
      "sentence": "Posted 1+ days ago\nAI Generated.",
      "distance": 1
    }
  ],
  "key_phrases": [
    {
      "text": "a mix",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "analyst actions",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "pipeline progress",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "broader market sentiment",
      "type": "noun_chunk",
      "category": "market_term"
    },
    {
      "text": "the key factors",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "the stock’s performance",
      "type": "noun_chunk",
      "category": "market_term"
    },
    {
      "text": "Positive Sentiment",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "Morgan Stanley",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "its price target",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "an \"equal weight\" rating",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "the company’s outlook",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "Positive Sentiment",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "a supplemental NDA",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "the FDA",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "its schizophrenia drug",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "strong relapse-prevention data",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "its psychiatric portfolio",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "Caplyta sNDA Submission\nPositive Sentiment",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "The company",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "a new Chief Medical Officer",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "its Electrophysiology business",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "a key MedTech segment",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "New CMO Appointment\nPositive Sentiment",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "three AI-driven medical device stocks",
      "type": "noun_chunk",
      "category": "market_term"
    },
    {
      "text": "its advances",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "surgical tech",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "AI-Driven Devices Article\nNeutral Sentiment",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "Wall Street analysts",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "their Q2 estimates",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "JNJ’s top- and bottom-line metrics",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "its July 16 earnings report",
      "type": "noun_chunk",
      "category": "financial_metric"
    },
    {
      "text": "Q2 Outlook\nNeutral Sentiment",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "recent forecast adjustments",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "the most accurate analysts",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "its Q2 print",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "Forecast Changes\nNeutral Sentiment",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "Eight analyst projections",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "JNJ’s long-term growth",
      "type": "noun_chunk",
      "category": "trend"
    },
    {
      "text": "R&D spend",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "Analyst Projections\nNeutral Sentiment",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "dividend-stock roundups",
      "type": "noun_chunk",
      "category": "market_term"
    },
    {
      "text": "its appeal",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "income-seeking investors",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "Top Healthcare Dividend Picks",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "Dividend Stocks",
      "type": "noun_chunk",
      "category": "market_term"
    },
    {
      "text": "Pre-market declines",
      "type": "noun_chunk",
      "category": "market_term"
    },
    {
      "text": "President Trump’s tariff threats",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "healthcare and industrial names",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "positive pipeline developments",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "analyst upgrades",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "upward momentum",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "JNJ shares",
      "type": "noun_chunk",
      "category": "market_term"
    },
    {
      "text": "macro trade-related concerns",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "some downward pressure",
      "type": "noun_chunk",
      "category": "general"
    },
    {
      "text": "$169",
      "type": "pattern",
      "category": "money"
    },
    {
      "text": "$171",
      "type": "pattern",
      "category": "money"
    },
    {
      "text": "$5",
      "type": "pattern",
      "category": "money"
    },
    {
      "text": "$300",
      "type": "pattern",
      "category": "money"
    },
    {
      "text": "earnings",
      "type": "pattern",
      "category": "financial_metric"
    },
    {
      "text": "growth",
      "type": "pattern",
      "category": "financial_metric"
    },
    {
      "text": "market",
      "type": "pattern",
      "category": "market_term"
    },
    {
      "text": "stock",
      "type": "pattern",
      "category": "market_term"
    },
    {
      "text": "stock",
      "type": "pattern",
      "category": "market_term"
    },
    {
      "text": "market",
      "type": "pattern",
      "category": "market_term"
    }
  ],
  "important_sentences": [
    {
      "text": "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "importance_score": 50,
      "entity_count": 7,
      "financial_keyword_count": 4,
      "money_count": 4,
      "company_count": 1,
      "sentiment": "negative"
    },
    {
      "text": "Positive Sentiment:\nMorgan Stanley raised its price target on JNJ from $169 to $171 and kept an \"equal weight\" rating, reflecting confidence in the company’s outlook.",
      "importance_score": 37,
      "entity_count": 5,
      "financial_keyword_count": 3,
      "money_count": 2,
      "company_count": 2,
      "sentiment": "positive"
    },
    {
      "text": "Johnson & Johnson (JNJ) shares moved today on a mix of analyst actions, pipeline progress and broader market sentiment.",
      "importance_score": 27,
      "entity_count": 5,
      "financial_keyword_count": 3,
      "money_count": 0,
      "company_count": 2,
      "sentiment": "neutral"
    },
    {
      "text": "Eight analyst projections on JNJ’s long-term growth—covering sales, R&D spend and margins—were published by Benzinga.",
      "importance_score": 26,
      "entity_count": 3,
      "financial_keyword_count": 4,
      "money_count": 0,
      "company_count": 2,
      "sentiment": "positive"
    },
    {
      "text": "JNJ submitted a supplemental NDA to the FDA for its schizophrenia drug Caplyta based on strong relapse-prevention data, bolstering its psychiatric portfolio.",
      "importance_score": 20,
      "entity_count": 3,
      "financial_keyword_count": 2,
      "money_count": 0,
      "company_count": 2,
      "sentiment": "positive"
    },
    {
      "text": "Posted 1+ days ago\nAI Generated.",
      "importance_score": 19,
      "entity_count": 6,
      "financial_keyword_count": 1,
      "money_count": 0,
      "company_count": 1,
      "sentiment": "neutral"
    },
    {
      "text": "AI-Driven Devices Article\nNeutral Sentiment:\nWall Street analysts released their Q2 estimates for JNJ’s top- and bottom-line metrics ahead of its July 16 earnings report.",
      "importance_score": 18,
      "entity_count": 4,
      "financial_keyword_count": 2,
      "money_count": 0,
      "company_count": 1,
      "sentiment": "neutral"
    },
    {
      "text": "Tariff Threats\nOverall, positive pipeline developments and analyst upgrades provided upward momentum for JNJ shares, while macro trade-related concerns applied some downward pressure.",
      "importance_score": 18,
      "entity_count": 1,
      "financial_keyword_count": 4,
      "money_count": 0,
      "company_count": 1,
      "sentiment": "positive"
    },
    {
      "text": "Benzinga detailed recent forecast adjustments from the most accurate analysts as JNJ gears up for its Q2 print.",
      "importance_score": 17,
      "entity_count": 3,
      "financial_keyword_count": 1,
      "money_count": 0,
      "company_count": 2,
      "sentiment": "neutral"
    },
    {
      "text": "Morgan Stanley Forecast\nPositive Sentiment:",
      "importance_score": 15,
      "entity_count": 4,
      "financial_keyword_count": 1,
      "money_count": 0,
      "company_count": 1,
      "sentiment": "positive"
    }
  ],
  "entity_statistics": {
    "total_entities": 36,
    "unique_entities": 23,
    "type_counts": {
      "ORG": 18,
      "DATE": 7,
      "MONEY": 6,
      "PRODUCT": 1,
      "CARDINAL": 2,
      "PERSON": 1,
      "GPE": 1
    },
    "type_distribution": {
      "ORG": 0.5,
      "DATE": 0.19444444444444445,
      "MONEY": 0.16666666666666666,
      "PRODUCT": 0.027777777777777776,
      "CARDINAL": 0.05555555555555555,
      "PERSON": 0.027777777777777776,
      "GPE": 0.027777777777777776
    },
    "most_common_entities": [
      [
        "JNJ",
        10
      ],
      [
        "Q2",
        3
      ],
      [
        "Benzinga",
        2
      ],
      [
        "K",
        2
      ],
      [
        "Johnson & Johnson",
        1
      ],
      [
        "today",
        1
      ],
      [
        "Morgan Stanley",
        1
      ],
      [
        "169",
        1
      ],
      [
        "171",
        1
      ],
      [
        "Morgan Stanley Forecast\n",
        1
      ]
    ],
    "entity_types_found": [
      "ORG",
      "DATE",
      "MONEY",
      "PRODUCT",
      "CARDINAL",
      "PERSON",
      "GPE"
    ],
    "company_entities": 18,
    "person_entities": 1,
    "financial_entities": 6,
    "entity_density": 0.12811387900355872
  },
  "financial_analysis": {
    "money_amounts": [
      "169",
      "171",
      "5",
      "K",
      "300",
      "K"
    ],
    "percentages": [],
    "companies": [
      "Johnson & Johnson",
      "JNJ",
      "Morgan Stanley",
      "JNJ",
      "Morgan Stanley Forecast\n",
      "JNJ",
      "FDA",
      "MedTech",
      "JNJ",
      "JNJ",
      "Benzinga",
      "JNJ",
      "JNJ",
      "Benzinga",
      "JNJ",
      "JNJ",
      "JNJ",
      "AI Generated"
    ],
    "people": [
      "Trump"
    ],
    "dates": [
      "today",
      "2025",
      "Q2",
      "July 16",
      "Q2",
      "Q2",
      "1+ days ago"
    ],
    "financial_terms": [
      "growth",
      "earnings",
      "stock",
      "market"
    ],
    "financial_metrics": [],
    "market_indicators": [
      "rating",
      "price",
      "target"
    ]
  },
  "temporal_analysis": {
    "dates": [
      "today",
      "2025",
      "Q2",
      "July 16",
      "Q2",
      "Q2",
      "1+ days ago"
    ],
    "time_expressions": [],
    "temporal_relationships": [
      "recent",
      "today"
    ],
    "quarters": [
      "Q2",
      "Q2",
      "Q2"
    ],
    "years": [
      "2025"
    ],
    "time_periods": []
  },
  "sentiment_analysis": {
    "positive_words": 9,
    "negative_words": 1,
    "positive_ratio": 0.03202846975088968,
    "negative_ratio": 0.0035587188612099642,
    "sentiment_score": 0.028469750889679717,
    "sentiment_label": "positive",
    "sentiment_strength": 0.028469750889679717,
    "confidence": 0.2846975088967972
  },
  "industry_analysis": {
    "dominant_industry": "healthcare",
    "industry_scores": {
      "tech": 3,
      "finance": 0,
      "healthcare": 6,
      "energy": 0,
      "retail": 0,
      "automotive": 0,
      "media": 0,
      "industrial": 1,
      "real_estate": 0,
      "telecom": 0,
      "food_beverage": 0,
      "travel": 0,
      "education": 0,
      "professional": 0,
      "mining": 0,
      "aerospace": 0,
      "environmental": 0,
      "cannabis": 0
    },
    "confidence": 0.6
  },
  "market_analysis": {
    "market_sentiment": "neutral",
    "bullish_indicators": 1,
    "bearish_indicators": 1,
    "market_conditions": {
      "volatility": "normal",
      "volume": "normal",
      "trend": "neutral"
    },
    "trading_activity": "normal"
  },
  "competitor_analysis": {
    "companies_mentioned": [
      "Johnson & Johnson",
      "JNJ",
      "Morgan Stanley",
      "JNJ",
      "Morgan Stanley Forecast\n",
      "JNJ",
      "FDA",
      "MedTech",
      "JNJ",
      "JNJ",
      "Benzinga",
      "JNJ",
      "JNJ",
      "Benzinga",
      "JNJ",
      "JNJ",
      "JNJ",
      "AI Generated"
    ],
    "competitive_context": [],
    "competitor_count": 18,
    "has_competitive_language": false
  },
  "risk_analysis": {
    "risk_sentences": [
      "Top Healthcare Dividend Picks\nDividend Stocks to Double Up\nTurn $5K into $300K with JNJ\nNegative Sentiment:\nPre-market declines were driven by President Trump’s tariff threats against Canada, creating headwinds for healthcare and industrial names.",
      "Tariff Threats\nOverall, positive pipeline developments and analyst upgrades provided upward momentum for JNJ shares, while macro trade-related concerns applied some downward pressure."
    ],
    "risk_count": 2,
    "risk_level": "medium"
  },
  "opportunity_analysis": {
    "opportunity_sentences": [
      "Eight analyst projections on JNJ’s long-term growth—covering sales, R&D spend and margins—were published by Benzinga."
    ],
    "opportunity_count": 1,
    "opportunity_level": "low"
  },
  "processing_metadata": {
    "timestamp": "2025-07-13T04:52:17.943775",
    "model_used": "en_core_web_trf",
    "text_length": 2004
  }
}